SMC Ltd.: SMC inks Bios autoinjector development deal

NEWS RELEASE: SMC Pharma Services Enters Autoinjector Development Agreement with a Biopharmaceutical Company for the Bios Platform Somerset, Wisconsin - SMC Pharma Services has entered into a development agreement with a commercial stage biopharmaceutical company specializing in care for genetic rare diseases to develop an autoinjector platform solution for a clinical trial in 2026. The...The post SMC inks Bios autoinjector development deal appeared first on Medical Design and Outsourcing.